Use of satiety peptides in assessing the satiating capacity of foods

Physiology and Behavior

Volumn 105, Issue 2, 2012, Pages 483-488

  Mars, Monica ^a,b   Stafleu, Annette ^a,c   de Graaf, Cees ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c TNO   (Netherlands)

Author keywords

Appetite regulation; Biological markers; Gastro intestinal hormones; Peptide hormones; Satiety response

Indexed keywords

CHOLECYSTOKININ; GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY;

ARTICLE; FOOD INTAKE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SATIETY;

CHOLECYSTOKININ; DATABASES, FACTUAL; EATING; FOOD; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INDIVIDUALITY; PEPTIDE YY; PEPTIDES; SATIATION; SATIETY RESPONSE;

EID: 80053532741     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.08.033     Document Type: Article

References (52)

1. Stubbs J., Ferres S., Horgan G. Energy density of foods: effects on energy intake. Crit Rev Food Sci Nutr 2000, 40:481.
2. Burton Freeman B. Dietary fiber and energy regulation. J Nutr 2000, 130:272S-275S.
3. Slavin J. Dietary fibre and satiety. Nutr Bull 2007, 32:32-42.
4. Kovacs E.M.R. Metabolically active functional food ingredients for weight control. Obes Rev 2006, 7:59.
5. Veldhorst M., Smeets A., Soenen S., Hochstenbach Waelen A., Hursel R., Diepvens K., et al. Protein-induced satiety: effects and mechanisms of different proteins. Physiol Behav 2008, 94:300-307.
6. Blundell J., de Graaf C., Hulshof T., Jebb S., Livingstone B., Lluch A., et al. Appetite control: methodological aspects of the evaluation of foods. Obes Rev 2010, 11:251-270.
7. Allison D.B., Baskin M.L. Handbook of assessment methods for eating behaviors and weight related problems: measures, theory and research 2009, SAGE, Los Angeles, CA.
8. de Graaf C., Blom W.A., Smeets P.A., Stafleu A., Hendriks H.F. Biomarkers of satiation and satiety. Am J Clin Nutr 2004, 79:946-961.
9. Delzenne N., Blundell J., Brouns F., Cunningham K., De Graaf K., Erkner A., et al. Gastrointestinal targets of appetite regulation in humans. Obes Rev 2010, 11:234-250.
10. Cummings D.E., Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007, 117:13-23.
11. Gutzwiller J.P., Drewe J., Goke B., Schmidt H., Rohrer B., Lareida J., et al. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol 1999, 276:R1541-R1544.
12. le Roux C.W., Borg C.M., Murphy K.G., Vincent R.P., Ghatei M.A., Bloom S.R. Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake. Ann Clin Biochem 2008, 45:93-95.
13. Sloth B., Davidsen L., Holst J.J., Flint A., Astrup A. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males. Am J Physiol Endocrinol Metab 2007, 293:E604-E609.
14. le Roux C.W., Batterham R.L., Aylwin S.J., Patterson M., Borg C.M., Wynne K.J., et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006, 147:3-8.
15. Delzenne N., Blundell J., Brouns F., Cunningham K., De Graaf K., Erkner A., et al. Gastrointestinal targets of appetite regulation in humans: ILSI supplement. Obes Rev 2010, 11:234-250.
16. Beglinger C., Degen L. Gastrointestinal satiety signals in humans-physiologic roles for GLP-1 and PYY?. Physiol Behav 2006, 89:460-464.
17. Gutzwiller J.P., Goke B., Drewe J., Hildebrand P., Ketterer S., Handschin D., et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999, 44:81-86.
18. Hall W.L., Millward D.J., Long S.J., Morgan L.M. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 2003, 89:239-248.
19. Pasman W.J., Blokdijk V.M., Bertina F.M., Hopman W.P., Hendriks H.F. Effect of two breakfasts, different in carbohydrate composition, on hunger and satiety and mood in healthy men. Int J Obes Relat Metab Disord 2003, 27:663-668.
20. Burton Freeman B., Davis P.A., Schneeman B.O. Interaction of fat availability and sex on postprandial satiety and cholecystokinin after mixed-food meals. Am J Clin Nutr 2004, 80:1207-1214.
21. Burton Freeman B. Sex and cognitive dietary restraint influence cholecystokinin release and satiety in response to preloads varying in fatty acid composition and content. J Nutr 2005, 135:1407-1414.
22. Zijlstra N., Mars M., de Wijk R.A., Westerterp-Plantenga M.S., Holst J.J., de Graaf C. Effect of viscosity on appetite and gastro-intestinal hormones. Physiol Behav 2009, 97:68-75.
23. Adam T.C.M. Glucagon-like peptide 1 stimulation in relation to body weight, chapter 2. Galactose in combination with guar gum stimulates GLP-1 release in healthy, normal weight subjects 2004, 171. Universiteit Maastricht, Maastricht.
24. Diplock A.T., Aggett P.J., Ashwell M., Bornet F., Fern E.B., Roberfroid M.B. Scientific concepts of functional foods in Europe: consensus document. Br J Nutr 1999, 81:S1-S27.
25. Schick R.R., Schusdziarra V., Mossner J., Neuberger J., Schroder B., Segmuller R., et al. Effect of CCK on food intake in man: physiological or pharmacological effect?. Z Gastroenterol 1991, 29:53-58.
26. Lieverse R.J., Jansen J.B., van de Zwan A., Samson L., Masclee A.A., Lamers C.B. Effects of a physiological dose of cholecystokinin on food intake and postprandial satiation in man. Regul Pept 1993, 43:83-89.
27. Ballinger A., McLoughlin L., Medbak S., Clark M. Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations. Clin Sci (Lond) 1995, 89:375-381.
28. Lieverse R.J., Jansen J.B., Masclee A.A., Lamers C.B. Satiety effects of a physiological dose of cholecystokinin in humans. Gut 1995, 36:176-179.
29. Gutzwiller J.P., Drewe J., Ketterer S., Hildebrand P., Krautheim A., Beglinger C. Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans. Am J Physiol Regul Integr Comp Physiol 2000, 279:R189-R195.
30. MacIntosh C.G., Morley J.E., Wishart J., Morris H., Jansen J.B., Horowitz M., et al. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 2001, 86:5830-5837.
31. Gutzwiller J.P., Degen L., Matzinger D., Prestin S., Beglinger C. Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men. Am J Physiol Regul Integr Comp Physiol 2004, 287:R562-R567.
32. Brennan I.M., Feltrin K.L., Horowitz M., Smout A.J., Meyer J.H., Wishart J., et al. Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1477-R1485.
33. Flint A., Raben A., Astrup A., Holst J.J. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998, 101:515-520.
34. Long S.J., Sutton J.A., Amaee W.B., Giouvanoudi A., Spyrou N.M., Rogers P.J., et al. No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man. Br J Nutr 1999, 81:273-279.
35. Nagell C.F., Wettergren A., Pedersen J.F., Mortensen D., Holst J.J. Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. Scand J Gastroenterol 2004, 39:353-358.
36. Neary N.M., Small C.J., Druce M.R., Park A.J., Ellis S.M., Semjonous N.M., et al. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005, 146:5120-5127.
37. Little T.J., Pilichiewicz A.N., Russo A., Phillips L., Jones K.L., Nauck M.A., et al. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses. J Clin Endocrinol Metab 2006, 91:1916-1923.
38. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY3-36 physiologically inhibits food intake. Nature 2002, 418:650.
39. Degen L., Oesch S., Casanova M., Graf S., Ketterer S., Drewe J., et al. Effect of peptide YY3-36 on food intake in humans. Gastroenterology 2005, 129:1430-1436.
40. Sloth B., Holst J.J., Flint A., Gregersen N.T., Astrup A. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endocrinol Metab 2007, 292:E1062-E1068.
41. Batterham R.L., Ffytche D.H., Rosenthal J.M., Zelaya F.O., Barker G.J., Withers D.J., et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007, 450:106-109.
42. Bakhøj S., Flint A., Holst J.J., Tetens I. Lower glucose-dependent insulinotropic polypeptide (GIP) response but similar glucagon-like peptide 1 (GLP-1), glycaemic, and insulinaemic response to ancient wheat compared to modern wheat depends on processing. Eur J Clin Nutr 2003, 57:1254-1261.
43. Frost G.S., Brynes A.E., Dhillo W.S., Bloom S.R., McBurney M.I. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal. Eur J Clin Nutr 2003, 57:293-298.
44. Nolan L.J., Guss J.L., Liddle R.A., Pi-Sunyer F.X., Kissileff H.R. Elevated plasma cholecystokinin and appetitive ratings after consumption of a liquid meal in humans. Nutrition 2003, 19:553-557.
45. Sanggaard K.M., Holst J.J., Rehfeld J.F., Sandstrom B., Raben A., Tholstrup T. Different effects of whole milk and a fermented milk with the same fat and lactose content on gastric emptying and postprandial lipaemia, but not on glycaemic response and appetite. Br J Nutr 2004, 92:447-459.
46. Adam T.C., Westerterp Plantenga M.S. Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects. Br J Nutr 2005, 93:845-851.
47. Weickert M.O., Mohlig M., Koebnick C., Holst J.J., Namsolleck P., Ristow M., et al. Impact of cereal fibre on glucose-regulating factors. Diabetologia 2005, 48:2343-2353.
48. Weickert M.O., Spranger J., Holst J.J., Otto B., Koebnick C., Möhlig M., et al. Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety. Br J Nutr 2006, 96:795-798.
49. Blom W.A., Lluch A., Stafleu A., Vinoy S., Holst J.J., Schaafsma G., et al. Effect of a high-protein breakfast on the postprandial ghrelin response. Am J Clin Nutr 2006, 83:211-220.
50. Doucet E., Laviolette M., Imbeault P., Strychar I., Rabasa-Lhoret R., Prud'homme D. Total peptide YY is a correlate of postprandial energy expenditure but not of appetite or energy intake in healthy women. Metabolism 2008, 57:1458-1464.
51. Sorensen L.B., Cueto H.T., Andersen M.T., Bitz C., Holst J.J., Rehfeld J.F., et al. The effect of salatrim, a low-calorie modified triacylglycerol, on appetite and energy intake. Am J Clin Nutr 2008, 87:1163-1169.
52. Vitaglione P., Lumaga R.B., Stanzione A., Scalfi L., Fogliano V. β-Glucan-enriched bread reduces energy intake and modifies plasma ghrelin and peptide YY concentrations in the short term. Appetite 2009, 53:338-344.